Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy [Corrigendum]
Han MK. Int J Chron Obstruct Pulmon Dis. 2020;15: 711–721 Page 718, Disclosure section, the disclosure statement was incomplete, the correct statement is “MeiLan K Han reports consulting fees from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Merck, Mylan and Novartis. She...
Guardado en:
Autor principal: | Han MK |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3396059b3ca24ddaac9616940254d02c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Underestimation of respiratory symptoms by smokers: a thorn in chronic obstructive pulmonary disease diagnosis
por: Evdoxia Gogou, et al.
Publicado: (2021) -
Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study
por: Tsung Yu, et al.
Publicado: (2017) -
Chronic obstructive pulmonary disease as a risk factor in primary care: a Canadian retrospective cohort study
por: Andrew Cave, et al.
Publicado: (2021) -
Association between chronic obstructive pulmonary disease and ventricular arrhythmia: a nationwide population-based cohort study
por: Chun-Chao Chen, et al.
Publicado: (2021) -
Stage 1 development of a patient-reported experience measure (PREM) for chronic obstructive pulmonary disease (COPD)
por: Susan Walker, et al.
Publicado: (2017)